Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > I think

<< Previous

Bullboard Posts

Next >>

Comment by Sailboatdreamon Aug 06, 2021 7:56am

178 Views

Post# 33662425

RE:RE:RE:RE:I think

Bio... I'm not going to pretend that I know more about this company (or the industry for that matter) than you do. Neither am I trying to convince or influence anyone. Just sharing information.

that said, I will allow myself to use "investing's most expensive words"... this time is different. The difference with past years are:

- SVA only company with viable, repeatable clinical results
- January results did get big pharma's attention... negotiating from there does take a bit of time
- $30M enables SVA to do things there were not able to before (hiring the right firms business side and the right contractors clinical side)

the proof will be in the upcoming NRs pudding.

<< Previous

Bullboard Posts

Next >>

Rock Tech notches official permit for German lithium refinery